Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Doctor-Patient care plan empower diabetes Self-Care?

NCT ID NCT07783451

Disease control Sponsor: Aysenur Aktemur Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 28, 2026 · Updated 3 times

Summary

This study tests whether a structured, shared follow-up plan, developed together by patients and their family doctors, can improve self-management skills in people with type 2 diabetes. Participants in the intervention group will attend three monthly in-person or video sessions with their physician, focusing on education, blood sugar monitoring, foot checks, and lifestyle changes. A control group will receive standard phone call follow-ups. The study aims to see if this collaborative approach boosts self-management regardless of a patient's health literacy level.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured shared follow-up plan combined with patient education
What this could lead to
If successful, this approach could offer a practical, low-cost way to help people with type 2 diabetes better manage their condition in primary care, potentially improving long-term health outcomes.
What could go wrong
This is a small, non-randomized study, so results may not be generalizable. The intervention's success may depend on individual patient engagement and physician consistency, and the short 3-month follow-up may not capture lasting effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

84 people

The number who actually took part.

Started

May 2021

Finished

Jan 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Must have a documented clinical diagnosis of Type 2 Diabetes Mellitus (T2DM). * Must be literate (able to read and write). * Must be able to monitor/measure blood glucose at home. Exclusion Criteria: * Inability to complete/apply the health literacy scale independently. * Currently receiving specialized diabetes care or treatment from a tertiary/specialized diabetes center. * Hospitalization due to diabetes-related complications during the course of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus, type 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Participation type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus, type 2

Contacts and locations

Locations

  • Marmara University Pendik Training and Research Hospital Tuzla Primary Health Center

    Istanbul, 34953, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.